BLIS Technologies Ltd
NZX:BLT

Watchlist Manager
BLIS Technologies Ltd Logo
BLIS Technologies Ltd
NZX:BLT
Watchlist
Price: 0.015 NZD -6.25% Market Closed
Market Cap: 19.2m NZD
Have any thoughts about
BLIS Technologies Ltd?
Write Note

BLIS Technologies Ltd
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BLIS Technologies Ltd
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
BLIS Technologies Ltd
NZX:BLT
Accounts Receivables
NZ$1.3m
CAGR 3-Years
-6%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
A
AFT Pharmaceuticals Ltd
NZX:AFT
Accounts Receivables
NZ$28m
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Cannasouth Ltd
NZX:CBD
Accounts Receivables
NZ$315.3k
CAGR 3-Years
69%
CAGR 5-Years
114%
CAGR 10-Years
N/A
Rua Bioscience Ltd
NZX:RUA
Accounts Receivables
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Greenfern Industries Ltd
NZX:GFI
Accounts Receivables
NZ$38.9k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

BLIS Technologies Ltd
Glance View

Market Cap
19.2m NZD
Industry
Pharmaceuticals

BLIS Technologies Ltd. engages in the development of healthcare products based on strains of bacteria that produce Bacteriocin activity. The company is headquartered in Dunedin, Otago. The company went IPO on 2001-07-30. The firm is also engaged in supply of healthcare ingredients and the manufacture of part and finished goods and food products for sale in domestic and international markets. The firm supplies BLIS-branded finished goods. The firm's products include BLIS K12 and BLIS M18, which are oral probiotics providing protection for ear, nose and throat health, halitosis (bad breath), gums and teeth health and immune support. The firm distributes its products through Stratum Nutrition in North America, NZPR Group in China, and Bluestone Pharma in Europe and Middle East. Its other BLIS branded products include Throat Guard EVERYDAY BLIS K12, Travel Guard BLIS K12, Fresh Breath Kit K12 and Toddler Protect BLIS K12 Powder for Toddlers.

BLT Intrinsic Value
0.01 NZD
Overvaluation 34%
Intrinsic Value
Price

See Also

What is BLIS Technologies Ltd's Accounts Receivables?
Accounts Receivables
1.3m NZD

Based on the financial report for Mar 31, 2024, BLIS Technologies Ltd's Accounts Receivables amounts to 1.3m NZD.

What is BLIS Technologies Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
-11%

Over the last year, the Accounts Receivables growth was -10%. The average annual Accounts Receivables growth rates for BLIS Technologies Ltd have been -6% over the past three years , -11% over the past five years .

Back to Top